Abstract:Background: Intracranial aneurysmal subarachnoid hemorrhage (aSAH) is a dangerous and highly fatal condition if ruptured. Significant advances have been made in the treatment of unruptured intracranial aneurysms (UIAs), but risk assessment methods for early diagnosis of intracranial aneurysm (IA) rupture remain limited. Methods: The datasets of IA GSE13353, GSE15629, and GSE54083 were downloaded through the Gene Expression Omnibus (GEO) database. Differentially expressed genes (DEGs) in unruptured and ruptured aneurysms were identified by R software using methods such as gene set enrichment analysis (GSEA) and weighted gene co-expression network analysis (WGCNA). Gene Ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) enrichment analysis were performed on the DEGs, and logistic regression models were used to construct a prediction model to discriminate UIA from healthy samples. We then performed GSEA on the genes in the model, followed by model validation using the GSE54083 dataset. Finally, we used the single-sample (ss)GSEA method to investigate the relationship between the diagnostic model genes and immune cells and immune function. Results: A total of 79 DEGs were obtained in patients with IA rupture compared to unruptured controls. The results of KEGG and GO enrichment analysis showed that neutrophil activation is involved in immune response, neutrophil mediated immunity, and positive regulation of angiogenesis. Interestingly, the results of immunoassays demonstrated that the break in IA may be associated with immune T cells. We used DEGs and WGCNA to determine common genes. The logistic regression model was trained based on 24 intersecting genes, and eventually retained 2 genes, KIAA0226L and UPP1, which we found to be reliable using the validation set, and GSEA revealed that the diagnostic model was associated with the Hippo signaling pathway and vascular smooth muscle contraction, and viral protein interaction with cytokine and cytokine were also associated. Finally explored using the CMap database, Tivozanib could be a potential small molecule drug for the treatment of ruptured intracranial aneurysms (RIAs). Conclusions: We identified new diagnostic genes associated with IA rupture, which may provide a new way of aneurysm diagnosis.

Differentially Expressed Genes Related with Extracellular Matrix in Intracranial Aneurysms by Genechip

Screening of Key Genes of Unruptured Intracranial Aneurysms by Using DNA Microarray Data Analysis Techniques.

Bioinformatics analysis of gene expression profile data to screen key genes involved in intracranial aneurysms

Integrative Analysis of Key Microrna-Mrna Complexes and Pathways in Aortic Aneurysm

Global Gene Expression Patterns and Somatic Mutations in Sporadic Intracranial Aneurysms

miR-566 expression and immune changes in patients with intracranial aneurysm

Bioinformatics analysis reveals potential biomarkers associated with the occurrence of intracranial aneurysms

Integrative bioinformatics analysis of miRNA and mRNA expression profiles and identification of associated miRNA-mRNA network in intracranial aneurysms

Gene expression analysis of ruptured and un-ruptured saccular intracranial aneurysm.

Exploration of the shared gene signatures and molecular mechanisms between Alzheimer's disease and intracranial aneurysm

Comparative Bioinformatics Analysis Between Proteomes of Rabbit Aneurysm Model and Human Intracranial Aneurysm with Label‐free Quantitative Proteomics

Comparative Analysis of Aneurysm Subtypes Associated Genes Based on Protein–protein Interaction Network

Identifying novel risk genes in intracranial aneurysm by integrating human proteomes and genetics

The Screening and Identification of Pathogenic Related Genes of Aortic Dissection

Featured Protein Analysis of Intracranial Aneurysms with Label-Free Quantitative Mass Spectrometry and Bioinformatics

Screening Key Genes for Abdominal Aortic Aneurysm Based on Gene Expression Omnibus Dataset

Abstract 15566: Dissecting the Genetic Architecture of Intracranial Aneurysms

Integrated Transcriptional Profiling Analysis and Immune-Related Risk Model Construction for Intracranial Aneurysm Rupture

Identifying and validating key genes mediating intracranial aneurysm rupture using weighted correlation network analysis and exploration of personalized treatment

Identifying Critical Genes Associated with Aneurysmal Subarachnoid Hemorrhage by Weighted Gene Co-Expression Network Analysis

RNA sequencing analysis revealed the induction of CCL3 expression in human intracranial aneurysms